| Numbers of patients |
110 |
51 |
59 |
|
| Age median (range) |
52 (35‐80) |
50 (31‐80) |
56 (40‐85) |
|
| Male/Female |
85/25 |
41/10 |
44/15 |
|
| BMI > 24 |
58/110 |
32/51(62,7%) |
42/59 (71,1%) |
0.46 |
| Risk factors for HIV infection |
MSM 43 (47,77%) PWID 19 (7,03%) HETERO 46(45.18%) OTHER 2 (1,48%) |
MSM 23 (44,96%) PWID 5 (6,20%) HETERO 22 (47,28%) OTHER 1 (1,55%) |
MSM 20 (50,35%) PWID 14 (7,80%) HETERO 24 (43,26%) OTHER 1 (1,41%) |
|
| Antiretroviral regimens |
PI‐ based 59 (52%) NO PI ‐ based 51 (48%) |
INI 13 (%) NNRTI 38 (%) |
PI 46 (%) PI+INI 12 (%) PI+NNRTI 1 (%) |
|
| Length of infection |
10.5 ± 7.7 |
8.1 ± 6.5 |
13,4 ± 7,6 |
0.0002 |
| Statin use |
16/110 |
4/51 (2,04%) |
12/59 (7,08%) |
0.11 |
| Other lower lipids drugs |
22/110 (24,2%) |
5/51 (2,55%) |
17/59 (10,03 %) |
0.11 |
| Anti‐hypertensive drugs |
29/110 (31,9%) |
13/51 (6,63) |
16/59 (9,44%) |
0.98 |
| Diabetes |
8/110 (8,8%) |
5/51 (2,55%) |
3/59 (1,77%) |
0.56 |
| Smoker |
45/110 (49,5%) |
17/51 (8,67 %) |
28/59 (16,52) |
0.19 |
| CDC CLASSIFICATION: C (late presenters) |
C: 7 (11,48%) |
C: 3 (5,88%) |
C: 4 (6,77%) |
0.86 |
| CD4+, cell/μL mean ± SD |
690,88 ± 311,38 |
691,42 ± 1104,42 |
690 ± 1167,43 |
0.99 |
| CD4+ NADIR , cell/μL mean ± SD |
317.56 ± 192.23 |
335 ± 194 |
270 ± 171.8 |
0.06 |
| Triglycerides (mg/dl) mean± SD |
145.8 ± 82.12 |
138,82 ± 91.47 |
153.34 ± 74.71 |
0.35 |
| Cholesterol mean (mg/dl) ± SD |
183.23 ± 33.13 |
178.64 ± 31.42 |
187.84 ± 34.99 |
0.15 |
| HDL mean (mg/dl) ± SD |
46.91 ± 12.99 |
49.78 ± 14.35 |
44.51 ± 11.45 |
0.03 |
| LDL mean (mg/dl) ± SD |
115 ± 31.17 |
109.64 ± 27.8 |
120 ± 34 |
0.08 |
| % of elevated triglycerides >150 mg/dl |
42/109 (38,53%) |
16/51 (31,37%) |
26/58 (44,82%) |
0.21 |
| % of elevated cholesterol > 200 mg/dl |
32/109 (29,35%) |
10/51 (19,6%) |
22/58 (37,93%) |
0.059 |
| % of elevated HDL > 50 mg/dl |
35/109 (32,11%) |
19/51 (37,25%) |
16/58 (27,58%) |
0.38 |
| % of elevated LDL > 160 mg/dl |
8/109 (7,33%) |
3/51 (5,88%) |
5/58 (8,62%) |
0.85 |
| Hypertension |
30/110 (33%) |
13/51 (25,4%) |
17/59 (28,8) |
0.86 |
| IMT > 1 CCA DX |
12/110 (10.9%) |
4/51 (7.84%) |
8/58 (13.55%) |
0.49 |
| IMT > 1 ICA DX |
29/110 (26.36%) |
9/49 (17.64%) |
20/59 (33.89%) |
0.11 |
| IMT > 1 CCA SX |
25/109 (22.93%) |
11/51 (21.56%) |
13/58 (22.41%) |
0.9 |
| IMT > 1 ICA SX |
30/108 (27.7%) |
9/50 (18%) |
21/58 (36.2%) |
0.05 |
| TOTAL PLAQUES DX |
24/110 (21.81%) |
10/51 (19.6%) |
14/59 (23.7%) |
0.77 |
| TOTAL PLAQUES SX |
28/110 (25.45%) |
9/51 (17.64%) |
18/59 (30.5%) |
0.17 |